Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of -115.56% is 61% above its 5-year average of -299.51%, near the high end of its 5-year range (-822.56%–-64.87%).
36.29% above its 12-month average of -181.38%.
Reported quarterly return on assets; no daily interpolation. Q2 FY2026 (2026-06-30): -14.73%.
RETURN ON ASSETS (ROA)
-115.56%
RETURN ON ASSETS (ROA) AVG TTM
-181.38%
RETURN ON ASSETS (ROA) AVG 3Y
-357.07%
RETURN ON ASSETS (ROA) AVG 5Y
-299.51%
RETURN ON ASSETS (ROA) AVG 10Y
N/A
RETURN ON ASSETS (ROA) AVG 15Y
N/A
RETURN ON ASSETS (ROA) AVG 20Y
N/A
CURRENT VS TTM AVG
+36.29%
CURRENT VS 3Y AVG
+67.64%
CURRENT VS 5Y AVG
+61.42%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-32.24%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
-258.44%
vs the sector median at left
MIRA Pharmaceuticals, Inc.
Market Cap
$30.36M
Return on Assets (ROA)
-115.56%
TTM Avg
-181.38%
3Y Avg
-357.07%
5Y Avg
-299.51%
Market Cap
$30.74M
Return on Assets (ROA)
-116.76%
TTM Avg
-76.53%
3Y Avg
-78.60%
5Y Avg
-71.54%
Market Cap
$30.52M
Return on Assets (ROA)
-45.77%
TTM Avg
-31.61%
3Y Avg
-54.99%
5Y Avg
-58.45%
Market Cap
$29.66M
Return on Assets (ROA)
-49.53%
TTM Avg
-17.16%
3Y Avg
-133.18%
5Y Avg
-213.67%
Market Cap
$30.66M
Return on Assets (ROA)
-13.65%
TTM Avg
-19.04%
3Y Avg
-14.35%
5Y Avg
-23.11%
Market Cap
$30.67M
Return on Assets (ROA)
-22.66%
TTM Avg
-23.43%
3Y Avg
-29.30%
5Y Avg
-40.97%
Market Cap
$30.85M
Return on Assets (ROA)
-39.14%
TTM Avg
-11.59%
3Y Avg
6.23%
5Y Avg
18.56%
Market Cap
$29.54M
Return on Assets (ROA)
-99.62%
TTM Avg
-39.99%
3Y Avg
-67.06%
5Y Avg
188.84%
Market Cap
$29.48M
Return on Assets (ROA)
-102.56%
TTM Avg
-232.33%
3Y Avg
-191.42%
5Y Avg
-176.42%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| MIRA Pharmaceuticals, Inc. (MIRA) | $30.36M | -115.56% | -181.38% | -357.07% | -299.51% |
| CervoMed Inc. (CRVO)vs › | $30.74M | -116.76% | -76.53% | -78.60% | -71.54% |
| BeyondSpring Inc. (BYSI)vs › | $30.52M | -45.77% | -31.61% | -54.99% | -58.45% |
| GridAI Technologies Corp. (GRDX)vs › | $29.66M | -49.53% | -17.16% | -133.18% | -213.67% |
| SCYNEXIS, Inc. (SCYX)vs › | $30.66M | -13.65% | -19.04% | -14.35% | -23.11% |
| MDxHealth S.A. (MDXH)vs › | $30.67M | -22.66% | -23.43% | -29.30% | -40.97% |
| Baird Medical Investment Holdings Limited (BDMD)vs › | $30.85M | -39.14% | -11.59% | 6.23% | 18.56% |
| Context Therapeutics Inc. (CNTX)vs › | $29.54M | -99.62% | -39.99% | -67.06% | 188.84% |
| Quantum Cyber N.V. (QUCY)vs › | $29.48M | -102.56% | -232.33% | -191.42% | -176.42% |
| Nortech Systems Incorporated (NSYS)vs › | $31.77M | 1.29% | -1.07% | 2.48% | 2.98% |
ROA
-115.6%
ROE
-116.1%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | -94.13% |
| 2024-12-31 | -268.64% |
| 2023-12-31 | -242.93% |
| 2022-12-31 | -822.56% |
| 2021-12-31 | -64.87% |
| 2020-12-31 | -303.93% |
